inositol and HIV
inositol has been researched along with HIV in 3 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "The monosaccharide substances inositol hexasulfate (IHS) and inositol hexaphosphoric acid (Phytic acid, IHP) were investigated for their antiviral effect on the human immunodeficiency virus (HIV) in vitro." | 7.67 | [Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro]. ( Kanai, M; Kunita, N; Kurimura, T; Miyano, K; Otake, T; Shimonaka, H; Ueba, N, 1989) |
| "The monosaccharide substances inositol hexasulfate (IHS) and inositol hexaphosphoric acid (Phytic acid, IHP) were investigated for their antiviral effect on the human immunodeficiency virus (HIV) in vitro." | 3.67 | [Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro]. ( Kanai, M; Kunita, N; Kurimura, T; Miyano, K; Otake, T; Shimonaka, H; Ueba, N, 1989) |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gongvatana, A | 1 |
| Harezlak, J | 1 |
| Buchthal, S | 1 |
| Daar, E | 1 |
| Schifitto, G | 1 |
| Campbell, T | 1 |
| Taylor, M | 1 |
| Singer, E | 1 |
| Algers, J | 1 |
| Zhong, J | 1 |
| Brown, M | 1 |
| McMahon, D | 1 |
| So, YT | 1 |
| Mi, D | 1 |
| Heaton, R | 1 |
| Robertson, K | 1 |
| Yiannoutsos, C | 1 |
| Cohen, RA | 1 |
| Navia, B | 1 |
| Lentz, MR | 1 |
| Kim, WK | 1 |
| Kim, H | 1 |
| Soulas, C | 1 |
| Lee, V | 1 |
| Venna, N | 1 |
| Halpern, EF | 1 |
| Rosenberg, ES | 1 |
| Williams, K | 1 |
| González, RG | 1 |
| Otake, T | 1 |
| Shimonaka, H | 1 |
| Kanai, M | 1 |
| Miyano, K | 1 |
| Ueba, N | 1 |
| Kunita, N | 1 |
| Kurimura, T | 1 |
Other Studies
3 other studies available for inositol and HIV
| Article | Year |
|---|---|
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartic Acid; | 2013 |
Alterations in brain metabolism during the first year of HIV infection.
Topics: Adult; Anti-Retroviral Agents; Aspartic Acid; Basal Ganglia; Choline; Frontal Lobe; GPI-Linked Prote | 2011 |
[Inhibitory effect of inositol hexasulfate and inositol hexaphosphoric acid (phytic acid) on the proliferation of the human immunodeficiency virus (HIV) in vitro].
Topics: Antiviral Agents; HIV; HTLV-I Infections; Humans; Inositol; Monocytes; Phytic Acid | 1989 |